March 3, 2020 / 12:35 PM / 3 months ago

BRIEF-Cytokinetics Announces Preclinical Data For AMG 594 Presented At Keystone Symposium On Heart Failure

March 3 (Reuters) - Cytokinetics Inc:

* CYTOKINETICS ANNOUNCES PRECLINICAL DATA FOR AMG 594 PRESENTED AT THE KEYSTONE SYMPOSIUM ON HEART FAILURE

* CYTOKINETICS INC - EXPECT TO COMPLETE SAD/MAD PHASE 1 STUDY OF AMG 594 IN 2H 2020 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below